Latest Listings And Ipos News

Tasmea Limited has launched a $43 million institutional placement to strengthen its balance sheet for future acquisitions, following a robust FY25 with significant profit growth and margin expansion. The company’s FY26 guidance signals continued momentum driven by organic growth and strategic acquisitions.

Wagners Holding Company Limited has secured $30 million through a strongly supported placement to fund growth in its construction materials and composite fibre technologies divisions.

Strata Investment Holdings PLC disputes a termination notice from 1000433639 Ontario Inc. regarding a binding letter agreement and is considering legal proceedings to enforce the deal or seek damages.

EMU NL has announced a non-renounceable entitlement offer to raise approximately $1.83 million to fund exploration at its Georgetown and Badja projects, while facing significant governance challenges ahead of a pivotal shareholder meeting.

333D Limited has ended its voluntary suspension, confirming its Bitcoin acquisitions align with ASX rules and outlining a disciplined treasury management strategy to support operational cash flow and growth.

Ausbil Investment Management has launched the Ausbil Active Dividend Income Fund – Active ETF, targeting tax effective income and potential capital growth through an actively managed Australian equities portfolio. The Fund will trade on the ASX AQUA market under ticker DIVI, featuring a 0.85% management fee and monthly distributions.

Cullen Resources Limited has completed the sale of its Wyloo iron ore royalty to Vox Royalty Corp for A$1.5 million in cash, while retaining a future payment right tied to mining commencement.

Barton Gold Holdings has upgraded its Challenger Gold Project resource to over 300,000 ounces of gold and is advancing feasibility studies targeting production by the end of 2026. The company plans a phased approach starting with tailings reprocessing before fresh rock mining.

Metal Powder Works Limited has completed a A$15 million institutional placement, strengthening its balance sheet to scale production and expand its market presence.

Samuel Terry Asset Management has launched an off-market takeover offer for all Eildon Capital Group stapled securities at A$0.80 per security, representing a notable premium over recent trading prices. The move aims to consolidate ownership and potentially delist Eildon Capital from the ASX.

Pathkey.AI’s TrialKey platform has demonstrated a 73% alignment with actual biotech trial outcomes, showing an average hypothetical share price gain of 76%, underscoring AI’s growing role in clinical trial prediction and biotech investing.

Harvey Norman Holdings Limited has responded to ASX inquiries confirming its FY25 earnings aligned with market expectations, despite the absence of formal guidance and complexities in analyst forecasting.